Acorda Therapeutics, Inc. (NASDAQ:ACOR) reported GAAP net income of $0.3 million for the quarter ended December 31, 2014, or $0.01 per diluted share. GAAP net income in the same quarter of 2013 was $6.2 million, or $0.15 per diluted share. For the full year ended December 31, 2014, the Company reported GAAP net income of $17.7 million, or $0.42 per diluted share. GAAP net income for the full year 2013 was $16.4 million, or $0.39 per diluted share. On Thursday shares of Acorda Therapeutics, Inc. (NASDAQ:ACOR) closed at $36.65. Company’s sales growth for last 5 years was 47.70% and EPS growth for next 5 years is recorded as 38.50%.
International Flavors & Fragrances Inc. (NYSE:IFF) reported better-than-expected results for fourth-quarter 2014. Adjusted earnings came in at $1.07 per share, above the Zacks Consensus Estimate of $1.03. Also, the bottom line improved 16.3% over the year-ago tally of 92 cents per share. International Flavors & Fragrances Inc. (NYSE:IFF) in last trading activity increased 7.26% to close at $114.77. Company weekly performance is 5.64% while its quarterly performance stands at 15.53%. International Flavors & Fragrances Inc. (NYSE:IFF) is 3.42% away from its 52 week high.
Agile Therapeutics, Inc. (NASDAQ:AGRX) announced that Al Altomari, President and Chief Executive Officer will present at the 2015 RBC Capital Markets’ Global Healthcare Conference on Wednesday February 25th, 2015 at 11:00 AM Eastern Standard Time in New York City, NY. On last trading day Agile Therapeutics, Inc. (NASDAQ:AGRX) decreased -0.17% to close at $8.98. Its volatility for the week is 5.82% while volatility for the month is 7.79%. Agile Therapeutics, Inc. (NASDAQ:AGRX) monthly performance is 40.61%.
The Board of Directors of Washington Federal, Inc. (NASDAQ:WAFD), announced a quarterly cash dividend of 13 cents per share. The current dividend will be payable on February 16, 2015 to common stockholders of record on February 2, 2015. Washington Federal Inc. (NASDAQ:WAFD) has 1.30% insider ownership while its institutional ownership stands at 85.90%. In last trading activity company’s stock closed at $21.06.
HB Fuller (NYSE:FUL) was upgraded by research analysts at TheStreet from a “hold” rating to a “buy” rating in a report released on Monday. On last trading day HB Fuller Co. (NYSE:FUL) increased 1.31% to close at $43.36. Its volatility for the week is 1.97% while volatility for the month is 3.18%. FUL’s sales growth for past 5 years was 11.30% and its EPS growth for past 5 years was -10.60%. HB Fuller Co. (NYSE:FUL) monthly performance is 5.04%.